Advances in Anticancer Agents in Medicinal Chemistry

Volume: 2

Indexed in: EBSCO, Ulrich's Periodicals Directory

Advances in Anticancer Agents in Medicinal Chemistry is an exciting eBook series comprising a selection of updated articles previously published in the peer-reviewed journal Anti-Cancer Agents in ...
[view complete introduction]

US $

*(Excluding Mailing and Handling)

Targeting Migrating Cells in Glioblastoma

Pp. 410-443 (34)

Ranjith Babu, Chunhui Di, Austin K. Mattox, Steve Harward and Cory Adamson


Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in humans. Despite aggressive surgical resection using state-of-theart neuroimaging and radiochemotherapy, the prognosis of GBM remains poor, with an estimated median survival of 12-14 months. At presentation, tumor cells have already have migrated into normal brain tissue beyond the main tumor mass. This accounts for the inability of surgery to cure this tumor. It is therefore imperative to better understand how inhibit GBM cell migration. In this review, we describe various potential targets that may be exploited to inhibit the migration GBM cells.


Glioblastoma, migration, signaling, stem cell.


Neurosurgery Section, Durham VA Medical Center, DUMC Box 2624, Durham, NC 27710, USA